Naris Nilubol
Overview
Explore the profile of Naris Nilubol including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
161
Citations
2407
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
12.
Taieb D, Nolting S, Perrier N, Fassnacht M, Carrasquillo J, Grossman A, et al.
Nat Rev Endocrinol
. 2023 Dec;
20(3):168-184.
PMID: 38097671
Adult and paediatric patients with pathogenic variants in the gene encoding succinate dehydrogenase (SDH) subunit B (SDHB) often have locally aggressive, recurrent or metastatic phaeochromocytomas and paragangliomas (PPGLs). Furthermore, SDHB...
13.
Cero C, Shu W, Reese A, Douglas D, Maddox M, Singh A, et al.
Endocrinology
. 2023 Nov;
164(12).
PMID: 37944134
Functional human brown and white adipose tissue (BAT and WAT) are vital for thermoregulation and nutritional homeostasis, while obesity and other stressors lead, respectively, to cold intolerance and metabolic disease....
14.
Grant R, Moroz B, Nilubol C, Cahoon E, Pfeiffer R, Nilubol N
Ann Surg
. 2023 Jul;
278(6):1032-1037.
PMID: 37450696
Objective: We aimed to determine the incidence of major cardiovascular and cerebrovascular events in elderly patients with primary hyperparathyroidism (pHPT) and the impact of parathyroidectomy. Summary Background Data: pHPT is...
15.
Fahrmann J, Wasylishen A, Pieterman C, Irajizad E, Vykoukal J, Wu R, et al.
J Clin Endocrinol Metab
. 2023 Jun;
108(12):3260-3271.
PMID: 37307230
Purpose: Patients with multiple endocrine neoplasia type 1 (MEN1) are predisposed to develop duodenopancreatic neuroendocrine tumors (dpNETs), and metastatic dpNET is the primary cause of disease-related mortality. Presently, there is...
16.
Sedlack A, Hatfield S, Kumar S, Arakawa Y, Roper N, Sun N, et al.
Cancers (Basel)
. 2023 Jun;
15(11).
PMID: 37296836
Adrenocortical cancer is an aggressive endocrine malignancy with an incidence of 0.72 to 1.02 per million people/year, and a very poor prognosis with a five-year survival rate of 22%. As...
17.
Chuki E, Graf A, Ninan A, Tora R, Abijo T, Bliss L, et al.
J Endocr Soc
. 2023 Jun;
7(5):bvad055.
PMID: 37284613
Context: Autologous implantation of parathyroid tissue is frequently utilized after parathyroidectomy in patients with heritable forms of primary hyperparathyroidism (PHPT). Data on long-term functional outcome of these grafts is sparse....
18.
Taieb D, Wanna G, Ahmad M, Lussey-Lepoutre C, Perrier N, Nolting S, et al.
Lancet Diabetes Endocrinol
. 2023 Apr;
11(5):345-361.
PMID: 37011647
Patients with germline SDHD pathogenic variants (encoding succinate dehydrogenase subunit D; ie, paraganglioma 1 syndrome) are predominantly affected by head and neck paragangliomas, which, in almost 20% of patients, might...
19.
Jha S, Welch J, Tora R, Lack J, Warner A, Del Rivero J, et al.
J Clin Endocrinol Metab
. 2023 Mar;
108(10):2686-2698.
PMID: 36935552
Context: Parathyroid cancer (PC) is a rare endocrine neoplasm with high mortality. While surgery is the treatment for patients with the disease, recurrence rates are high, and patients usually succumb...
20.
Ramamoorthy B, Nilubol N
Surg Oncol Clin N Am
. 2023 Mar;
32(2):315-325.
PMID: 36925188
Multiple endocrine neoplasia type 1 syndrome (MEN1) is a disease caused by mutations in the MEN1 tumor suppressor gene leading to hyperparathyroidism, pituitary adenomas, and entero-pancreatic neuroendocrine tumors. Pancreatic neuroendocrine...